Outcome-Specific Prognostic Performance of Pneumonia Severity Assessment Tools for Predicting a Spectrum of Multiple Clinical Events
摘要
While guidelines recommend severity scores for community-acquired pneumonia (CAP), their predictive accuracy across diverse clinical scenarios—from acute instability to resource utilization—remains incompletely understood.
ObjectivesTo evaluate the performance of five severity scores (CURB-65, PSI, qSOFA, APUA, BAR) in predicting acute deterioration, complications, and hospital readmission in CAP.
MethodsThis retrospective cohort study included 332 adults hospitalized with CAP (January 2020–June 2025). Primary outcomes were ICU admission, in-hospital mortality, and sepsis. Secondary outcomes included pleural effusion, prolonged hospitalization (≥ 7 days), and 30-day revisits. Discrimination was assessed using area under the curve (AUC) and pairwise DeLong tests.
ResultsAmong 332 patients (median age 73.0 years; 60.2% male), 14.5% required ICU admission, 8.4% died, and 42.2% required prolonged hospitalization. Demonstrating a clear separation in performance, qSOFA showed the highest discrimination for in-hospital mortality (AUC 0.781) and sepsis (AUC 0.762), outperforming CURB-65 (p < 0.05). For resource utilization, APUA significantly outperformed all other scores in predicting prolonged hospitalization (AUC 0.719; p < 0.05) and, alongside PSI, showed superior discrimination for pleural effusion (AUC > 0.70). None of the scores successfully predicted 30-day respiratory-related revisits (AUC range 0.433–0.488).
ConclusionsPneumonia severity scores demonstrate a domain-specific performance profile. qSOFA is the superior tool for predicting acute physiological instability (sepsis/mortality), whereas the multidimensional APUA score is the most robust predictor for intermediate-term complications and length of stay. Post-discharge revisits appear to be driven by factors beyond initial biological severity.